
Journal of medicinal chemistry p. 1003 - 1007 (1984)
Update date:2022-07-29
Topics:
Hacksell
Johansson
Arvidsson
Nilsson
Hjorth
Carlsson
Wikstroem
Sanchez
Lindberg
C1-Methylated derivatives of the potent dopaminergic agonist 5-hydroxy-2-(di-n-propylamino)tetralin (6) have been synthesized and tested for central dopamine (DA) receptor stimulating activity, by using biochemical and behavioral tests in rats. Both cis- and trans-5-hydroxy-1-methyl-2-(di-n-propylamino) tetralin (4 and 3) may be classified as central DA-receptor agonists, albeit of lower potency than 6. The results obtained indicate that both 4 and 3 display DA-autoreceptor stimulation capacity. However, only one of the isomers, trans-3, is able to elicit clear-cut postsynaptic DA receptor agonist actions at larger doses. 5-Hydroxy-1,1-dimethyl-2-(n-propylamino) tetralin (5) was found to be inactive.
View MoreNanjing Manhay Medical Technology Co.,Ltd
Contact:86-25-18061468449 13951924040
Address:Building5,Fuzhong Park,Xuanwu District
Shaanxi Sinuote Biotech Co.,Ltd
Contact:+86-29-68859685
Address:No 18,Taiyuan Road ,Xi'an city ,China
Contact:+86-579-85206992
Address:No 451 chouzhou north road ,room 1106 int'l business center , yiwu ,china
Shanghai Hanshare Industry Co.,Ltd.
Contact:86 21 20960688
Address:RM902-903,Building E, Wanda Plaza,No.26,Zhoukang Road, Pudong District, Shanghai, China
Wuxi D-Stone International Co., Ltd.
Contact:+86-510-82740567
Address:21F Hengtong Int'l Centre, 215Zhongshan Road, Wuxi, Jiangsu,China
Doi:10.1021/acs.orglett.0c01204
(2020)Doi:10.1055/s-2008-1078252
(2008)Doi:10.1021/jo4007128
(2013)Doi:10.1016/S0040-4020(01)85619-2
(1992)Doi:10.1080/10242422.2017.1289183
(2017)Doi:10.1021/jacs.1c01602
(2021)